Hysteropexy in the treatment of uterine prolapse stage 2 or higher: laparoscopic sacrohysteropexy versus sacrospinous hysteropexy-a multicentre randomised controlled trial (LAVA trial).
van IJsselmuiden MN, van Oudheusden A, Veen J, van de Pol G, Vollebregt A, Radder CM, Housmans S, van Kuijk S, Deprest J, Bongers MY, van Eijndhoven H.
BJOG. 2020 Sep;127(10):1284-1293. doi: 10.1111/1471-0528.16242. Epub 2020 May 10.
Laparoscopic suture sacrohysteropexy: A meshless uterine- sparing technique for surgical management of uterine prolapse.
Thanatsis N, Ben Zvi M, Kupelian AS, Vashisht A.
Facts Views Vis Obgyn. 2023 Jun;15(2):171-173. doi: 10.52054/FVVO.15.2.075.
Surgical treatment of primary uterine prolapse: a comparison of vaginal native tissue surgical techniques.
Husby KR, Larsen MD, Lose G, Klarskov N.
Int Urogynecol J. 2019 Nov;30(11):1887-1893. doi: 10.1007/s00192-019-03950-9. Epub 2019 May 3.
Prospective analysis of transvaginal mesh hysteropexy in the treatment of uterine prolapse.
Khandwala S, Cruff J.
Int Urogynecol J. 2021 Aug;32(8):2241-2247. doi: 10.1007/s00192-020-04590-0. Epub 2020 Nov 11.
Treatment of uterine prolapse stage 2 or higher: a randomized multicenter trial comparing sacrospinous fixation with vaginal hysterectomy (SAVE U trial).
Detollenaere RJ, den Boon J, Stekelenburg J, Alhafidh AH, Hakvoort RA, Vierhout ME, van Eijndhoven HW.
BMC Womens Health. 2011 Feb 15;11:4. doi: 10.1186/1472-6874-11-4.
Systematic classification of uterine cervical elongation in patients with pelvic organ prolapse.
Mothes AR, Mothes H, Fröber R, Radosa MP, Runnebaum IB.
Eur J Obstet Gynecol Reprod Biol. 2016 May;200:40-4. doi: 10.1016/j.ejogrb.2016.02.029. Epub 2016 Mar 3.
Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol).
van IJsselmuiden MN, Coolen AL, Detollenaere RJ, den Boon J, Bongers M, van de Pol G, Vollebregt A, Radder CM, Deprest J, van Eijndhoven HW.
BMC Womens Health. 2014 Sep 17;14:112. doi: 10.1186/1472-6874-14-112.
Risk factors for coexistence of cervical elongation in uterine prolapse.
Hsiao SM, Chang TC, Chen CH, Li YI, Shun CT, Lin HH.
Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:94-97. doi: 10.1016/j.ejogrb.2018.08.011. Epub 2018 Aug 8.
Expression of Heparanase in uterosacral ligaments of women with or without uterine prolapse.
Ben-Zvi M, Herman HG, Schreiber L, Sagiv R, Bar J, Condrea A, Ginath S.
Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:110-113. doi: 10.1016/j.ejogrb.2019.11.024. Epub 2019 Nov 21.
Low expression of collagen type-1 in sacrouterine ligament as risk factor of stage III-IV uterine prolapse.
Mega Putra IG, Ngurah Warsita IG, Suwiyoga K, Fajar Manuaba IBG, Budiana ING, Putra Wiradnyana AAG.
Eur J Obstet Gynecol Reprod Biol. 2020 Jun;249:32-36. doi: 10.1016/j.ejogrb.2020.01.027. Epub 2020 Jan 22.
